Table 1.
Demographic and Clinical Characteristics of 11 485 Patients Initiating Combination Antiretroviral Therapy in the Centers for AIDS Research Network of Integrated Clinical Systems, 1996–2011
| Characteristic | No. of Patients |
|---|---|
| Total | 11 485 |
| Female sex | 2304 (20.1%) |
| Age, median (IQR) | 38 (32–45) |
| Race | |
| White | 4933 (43.0%) |
| Black | 4677 (40.7%) |
| Hispanic | 1273 (11.1%) |
| Other/unknown | 602 (5.2%) |
| Injection drug user | 2156 (18.8%) |
| Men who have sex with men | 6328 (55.1%) |
| Antiretroviral exposure prior to first ART | 3207 (27.9%) |
| ART initiation year, median (IQR) | 2004 (2000–2007) |
| ART regimen type | |
| PI | 5443 (47.3%) |
| NNRTI | 4835 (42.1%) |
| ≥3 NRTIs | 570 (5.0%) |
| NNRTI + PI | 441 (3.8%) |
| Othera | 196 (1.7%) |
| CD4 count, cells/mm3, median (IQR) | 202 (61–338) |
| HIV RNA level, log10 copies/mL, median (IQR) | 4.8 (4.3–5.3) |
Abbreviations: ART, combination antiretroviral therapy; HIV, human immunodeficiency virus; IQR, interquartile range; NNRTI, nonnucleoside reverse transcriptase inhibitor; NRTI, nucleoside reverse transcriptase inhibitor; PI, protease inhibitor.
a Includes regimens with an integrase inhibitor, fusion inhibitor, or entry inhibitor.